Literature DB >> 9873535

Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics.

C O Ogbu1, M N Qabar, P D Boatman, J Urban, J P Meara, M D Ferguson, J Tulinsky, C Lum, S Babu, M A Blaskovich, H Nakanishi, F Ruan, B Cao, R Minarik, T Little, S Nelson, M Nguyen, A Gall, M Kahn.   

Abstract

The general approach of using a bicyclic template to produce inhibitors of the protease superfamily of enzymes has been investigated. The Diels Alder cycloaddition reaction on solid support has been found to be highly efficient for the synthesis of libraries of compounds that mimic the beta-strand secondary structure of proteins. Several potent and selective inhibitors of proteases have been discovered.

Mesh:

Substances:

Year:  1998        PMID: 9873535     DOI: 10.1016/s0960-894x(98)00420-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.

Authors:  Graeme S Cottrell; Silvia Amadesi; Stella Pikios; Eric Camerer; J Adam Willardsen; Brett R Murphy; George H Caughey; Paul J Wolters; Shaun R Coughlin; Anders Peterson; Wolfgang Knecht; Charalabos Pothoulakis; Nigel W Bunnett; Eileen F Grady
Journal:  Gastroenterology       Date:  2007-04-13       Impact factor: 22.682

2.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].

Authors:  Katayoon H Emami; Cu Nguyen; Hong Ma; Dae Hoon Kim; Kwang Won Jeong; Masakatsu Eguchi; Randall T Moon; Jia-Ling Teo; Se Woong Oh; Hak Yeop Kim; Sung Hwan Moon; Jong Ryul Ha; Michael Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

3.  Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma.

Authors:  Cu Nguyen; Jia-Ling Teo; Akihisa Matsuda; Masakatsu Eguchi; Emil Y Chi; William R Henderson; Michael Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.